Skip to main content
. 2022 Sep 14;2(1):e156. doi: 10.1017/ash.2022.292

Table 3.

Primary and Secondary Outcomes

Outcome Preimplementation
Group
(n=156)
Postimplementation
Group
(n=141)
P
Value
Antifungal administered within 72 h of Candida result; no. (%) 75 (48.1) 48 (34.0) .02
Antifungal administered within 73–240 h Candida result; no. (%) 2 (1.3) 5 (3.5) .26
Antifungal duration, median d (IQR) 4.0 (1–7) 3.0 (1–6) .43

Note. IQR, interquartile range.